Blogs about: Trubion Pharmaceuticals
Featured Blog
Emergent BioSolutions Reports Financial Results for Full Year 2010
2010 revenues of $286.2 million 2010 net income of $51.7 million, or $1.63 per share, representing ninth consecutive year of profitability 2010 cash, investments and accounts receivable balance of $21… more →
El-Hibri Fuad Blog
Emergent BioSolutions Reports Financial Results for Full Year 2010
wrote 2 years ago: 2010 revenues of $286.2 million 2010 net income of $51.7 million, or $1.63 per share, representing n … more →
Emergent BioSolutions Reports Financial Results for Full Year 2010
wrote 2 years ago: 2010 revenues of $286.2 million 2010 net income of $51.7 million, or $1.63 per share, representing n … more →
Emergent BioSolutions Reports Financial Results for Full Year 2010
wrote 2 years ago: 2010 revenues of $286.2 million 2010 net income of $51.7 million, or $1.63 per share, representing n … more →
Emergent BioSolutions Reports Financial Results for Full Year 2010
wrote 2 years ago: 2010 revenues of $286.2 million 2010 net income of $51.7 million, or $1.63 per share, representing n … more →
Emergent BioSolutions Completes Acquisition of Trubion Pharmaceuticals
wrote 2 years ago: ROCKVILLE, Md., Oct 28, 2010 (BUSINESS WIRE) — Emergent BioSolutions Inc. (NYSE:EBS) today announced … more →
Emergent BioSolutions Completes Acquisition of Trubion Pharmaceuticals
wrote 2 years ago: ROCKVILLE, Md., Oct 28, 2010 (BUSINESS WIRE) — Emergent BioSolutions Inc. (NYSE:EBS) today announced … more →
Emergent BioSolutions Completes Acquisition of Trubion Pharmaceuticals
wrote 2 years ago: ROCKVILLE, Md., Oct 28, 2010 (BUSINESS WIRE) — Emergent BioSolutions Inc. (NYSE:EBS) today announced … more →
Emergent BioSolutions Completes Acquisition of Trubion Pharmaceuticals
wrote 2 years ago: ROCKVILLE, Md., Oct 28, 2010 (BUSINESS WIRE) — Emergent BioSolutions Inc. (NYSE:EBS) today announced … more →
Emergent BioSolutions completes aquisition of Trubion Pharmaceuticals
wrote 2 years ago: Emergent BioSolutions has announced that it has completed the acquisition of Trubion Pharmaceuticals … more →
Emergent BioSolutions to Acquire Trubion Pharmaceuticals
wrote 2 years ago: Trubion provides promising clinical-stage therapeutic candidates in the targeted disease areas of on … more →
Emergent BioSolutions to Acquire Trubion Pharmaceuticals
wrote 2 years ago: Trubion provides promising clinical-stage therapeutic candidates in the targeted disease areas of on … more →
Emergent BioSolutions to Acquire Trubion Pharmaceuticals
wrote 2 years ago: Trubion provides promising clinical-stage therapeutic candidates in the targeted disease areas of on … more →
Emergent BioSolutions to Acquire Trubion Pharmaceuticals
wrote 2 years ago: Trubion provides promising clinical-stage therapeutic candidates in the targeted disease areas of on … more →
Wyeth extends collaboration with Trubion
wrote 3 years ago: Trubion Pharmaceuticals has announced that Wyeth Pharmaceuticals has exercised its option under the … more →
